The incidence of thyroid cancer is increasing rapidly in the United States and the past few years have seen dramatic shifts in the management of papillary and follicular thyroid cancer.
A Swing of the Pendulum?
For years, radical surgery was the only treatment for head and neck cancer (HNSCC).
First Two Patients Respond to Gene Therapy in Melanoma Study
Gene therapy as a treatment for cancer has advanced from the theoretical to the possible: in a pilot study published in August in the journal Science, investigators reported that two of 17 patients with advanced melanoma responded to a treatment known as genetically engineered therapy.
Pediatric Recurrent Respiratory Papillomatosis: Fighting the Battle of a Rare But Serious Disease
IOM Report: Asbestos Can Cause Laryngeal Cancer
A committee of the Institute of Medicine (IOM) here has concluded that there is enough scientific evidence to state that exposure to asbestos causes cancer of the larynx.
HPV-Oropharyngeal Cancer Link May Affect Cancer Screening and Prognosis: The link offers potential for improved detection and prevention, but more research is needed
Gene Therapy: A Promising Role in Otolaryngology
After a hiatus associated with a checkered past, gene therapy is again showing promise in several fields of medicine, and otolaryngology is no exception.
Recurrent Respiratory Papillomatosis: Researchers Advancing Toward Prevention
Recurrent respiratory papillomatosis (RRP) begins with a pretty small virus, relatively speaking, but it can lead to some pretty big problems for both the patient and the treating physician.
Keeping Watch for Skin Cancers on the Head and Neck
Award-Winning Theses Shed New Light on Treatment Modalities, Disease Etiology
Consider this: Over the past two decades, data from both the Surveillance, Epidemiology, and End Results (SEER) program and the National Cancer Database indicate that the survival rates for patients with laryngeal cancer have decreased.
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- Next Page »